Viibryd and Parkinson's disease - a phase IV clinical study of FDA data

Summary:

Parkinson's disease is reported as a side effect among people who take Viibryd (vilazodone hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Rexulti, and have Narcolepsy.

The phase IV clinical study analyzes which people have Parkinson's disease when taking Viibryd. It is created by eHealthMe based on reports of 10,186 people who have side effects when taking Viibryd from the FDA, and is updated regularly.

What is Viibryd?

Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. eHealthMe is studying from 11,106 Viibryd users. Check the latest studies of Viibryd.

What is Parkinson's disease?

Parkinson's disease is found to be associated with 1,115 drugs and 1,625 conditions by eHealthMe. Check the latest studies of Parkinson's disease.

On Jul, 19, 2026

10,186 people reported to have side effects when taking Viibryd.
Among them, 25 people (0.25%) have Parkinson's disease.

Could Viibryd cause Parkinson's disease?

Among these 25 people:

How long have people been on Viibryd when they have Parkinson's disease? *

What is the gender of people who have Parkinson's disease when taking Viibryd? *

female: 36.36 %
male: 63.64 %

What is the age of people who have Parkinson's disease when taking Viibryd? *

What are other drugs people take besides Viibryd? *

What are other side effects people have besides Parkinson's disease? *

Tardive Dyskinesia (a disorder that involves involuntary movements): 7 people, 28.00%
Nausea (feeling of having an urge to vomit): 5 people, 20.00%
Weight Decreased: 3 people, 12.00%
Renal Injury (kidney injury): 2 people, 8.00%
Weakness: 2 people, 8.00%
Drug Ineffective: 1 person, 4.00%
Akathisia (a movement disorder characterized by a feeling of inner restlessness): 1 person, 4.00%
Blood Creatine Increased: 1 person, 4.00%
Constipation: 1 person, 4.00%
Diarrhea: 1 person, 4.00%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 20.00%
Irritable Bowel Syndrome: 3 people, 12.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 12.00%
Urinary Retention (the inability to completely or partially empty the bladder): 3 people, 12.00%
Insomnia (sleeplessness): 2 people, 8.00%
Bipolar Disorder (mood disorder): 2 people, 8.00%
Tardive Dyskinesia (a disorder that involves involuntary movements): 2 people, 8.00%
On And Off Phenomenon: 1 person, 4.00%
Osteoporosis (bones weak and more likely to break): 1 person, 4.00%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 1 person, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Viibryd and have Parkinson's disease?

- Check whether Parkinson's disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Viibryd:

Viibryd (11,106 reports)

Browse all side effects of Viibryd:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Parkinson's disease:

Parkinson's disease (1,115 drugs)

Browse all the conditions that are associated with Parkinson's disease:

Parkinson's disease (1,625 conditions)

Related publications that referenced our studies

Woulfe JM, Gray MT, Gray DA, Munoz DG, Middeldorp JM, "Hypothesis: a role for EBV-induced molecular mimicry in Parkinson's disease", Parkinsonism & related disorders, 2014 Jul .
Woulfe JM, Gray MT, Gray DA, Munoz DG, Middeldorp JM, "Hypothesis: a role for EBV-induced molecular mimicry in Parkinson's disease", Parkinsonism & related disorders, 2014 Jul .

How the study uses the data?

The study uses data from the FDA. It is based on vilazodone hydrochloride (the active ingredients of Viibryd) and Viibryd (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.